Funder: Canadian Institutes of Health Research
Due Dates (Anticipated): February 2027 (Pre-proposal) | June 2027 (Full proposal)
Funding Amounts: Up to Can$200,000 annually for three years (Can$600,000 total), supporting one Canadian team component
Summary: Supports transnational research on veterinary and agricultural antimicrobial use and resistance transmission to humans and the environment.
Key Information: CIHR funds only Topic 3 projects that include human health research activities.
Description
CIHR’s participation in the European Partnership on One Health Antimicrobial Resistance (EUP OHAMR) call supports innovative, cost-effective AMR treatment options. The Canadian contribution is sponsored by the AMR Research Initiative under the leadership of CIHR’s Institute of Infection and Immunity. It takes a One Health approach connecting human, animal, plant and environmental health.
Canadian-funded projects must address Topic 3: how veterinary and agricultural antimicrobials affect the emergence and transmission of resistance to humans and the environment. Research should assess antibacterial and antifungal drug mechanisms, formulations, administration routes and treatment regimens, and improve dosage, delivery or treatment practices to reduce cross-resistance and transmission. The goal is evidence supporting policies that reserve certain antimicrobials exclusively for human use.
